Trial
NCT02134912
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Adenocarcinoma of the Lung
Intervention
crizotinib
Why stopped
science has moved forward and there is no intent to complete the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-20